Clinical Trial Detail

NCT ID NCT02101385
Title Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoosier Cancer Research Network
Indications

triple-receptor negative breast cancer

Therapies
Age Groups: adult

No variant requirements are available.